Programmed cell death: the pathways to severe COVID-19?

Two years after the emergence of SARS-CoV-2, our understanding of COVID-19 disease pathogenesis is still incomplete. Despite unprecedented global collaborative scientific efforts and rapid vaccine development, an uneven vaccine roll-out and the emergence of novel variants of concern such as omicron...

Descripción completa

Detalles Bibliográficos
Autores principales: Bader, Stefanie M., Cooney, James P., Pellegrini, Marc, Doerflinger, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2022
Materias:
Cell Death & Injury
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022977/
https://www.ncbi.nlm.nih.gov/pubmed/35244141
http://dx.doi.org/10.1042/BCJ20210602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022977/
https://www.ncbi.nlm.nih.gov/pubmed/35244141
http://dx.doi.org/10.1042/BCJ20210602

Ejemplares similares